The present invention relates to combination pharmaceutical composition comprising an activated potentiated form of an antibody to gamma interferon and an activated potentiated form of an antibody to S 100 protein and method of treating multiple sclerosis and other neurodegenerative diseases as well as the diseases and conditions associated with neuroinfections.